Nov 01, 2024 Life sciences M&A roundup: October 2024 By Ross McNaughton Sarah Cole We have seen a general plateauing of biotech M&A in the last few months, but we've kept tabs on a few deals of note in October, keeping...
Oct 18, 2024 "Arrangements" that disqualify new EMI option grants: updated HMRC guidance By Elliot Michaelson Taylor HMRC has released updated guidance which impacts the grant of new Enterprise Management Incentive (EMI) options. The guidance sets out...
Oct 15, 2024 Interpretation of Art 22 EUMR quashed by Court of Justice By Paolo Palmigiano On 3 September 2024, the Court of Justice of the European Union (CJEU) annulled a decision by the European Commission regarding the...
Oct 15, 2024 Novartis and patent litigation to stop rival By Paolo Palmigiano Novartis has avoided antitrust charges in the EU and Switzerland after both regulators concluded their investigations into the company’s...
Oct 09, 2024 UK government launches new Regulatory Innovation Office to reduce red tape By Debbie Heywood On 8 October 2024, acting on a manifesto commitment, the UK's Department for Science, Innovation and Technology, announced the launch of...
Oct 03, 2024 CMA warning letters mapped By Elisabetta Rotondo The CMA has published a map of warning and advisory letters sent to businesses between 2018 and 2023. The numbers show that the CMA does...
Oct 01, 2024 Irreparable harm unnecessary for UPC PI By Paul England Is it necessary to demonstrate that an applicant will suffer irreparable harm for an applicant to obtain a preliminary injunction (PI) in...
Sep 27, 2024 Life sciences M&A roundup: September 2024 By Ross McNaughton Sarah Cole After a spate of summer announcements, biotech M&A has taken a break in September with only a handful of deals reported and only one with...
Sep 25, 2024 Spotlight on medical devices: FDA, MHRA and EU Commission approaches to medical device regulations By Nick Vollers We were pleased to host Jennifer D. Newberger (Hyman Phelps & McNamara), Jenifer Hannon (BSI) and Sue Spencer (QServe) for a panel...
Sep 18, 2024 Advertising medical devices: lack of harmonisation across Europe By Alice Matthews At our recent Spotlight on medical devices event, Taylor Wessing's European team discussed the differing approaches taken to the...
Sep 17, 2024 The UPC injuncts directors as "intermediaries" to infringement By Paul England In its latest infringement decision, Koninklijke Philips v Belkin (UPC_CFI_390/2023) the Local Division Munich has provided guidance on...
Sep 04, 2024 Ten year extension to EIS and VCT announced By Liz Wilson HM Treasury has just confirmed that the Enterprise Investment Scheme and Venture Capital Trust Scheme have both been extended by a...